World Anti-Doping Code 2015

1 Jan 2015

World Anti-Doping Code 2015 / World Anti-Doping Agency (WADA). - Montreal : WADA, 2015

The World Anti-Doping Code was first adopted in 2003, took effect in 2004, and was then amended effective 1 January 2009. The following document incorporates revisions to the World Anti-Doping Code that were approved by the World Anti-Doping Agency Foundation Board in Johannesburg, South Africa on 15 November 2013. The revised 2015 World Anti-Doping
Code is effective as of 1 January 2015.


The World Anti-Doping Code (Code) is the core document that harmonizes anti-doping policies, rules and regulations within sport organizations and among public authorities around the world. It works in conjunction with six International Standards which aim to foster consistency among anti-doping organizations in various areas: testing; laboratories; Therapeutic Use Exemptions (TUEs); the List of Prohibited Substances and Methods; the protection of privacy and personal information; and Code Compliance by Signatories.

This unified approach addresses problems that previously arose from disjointed and uncoordinated anti-doping efforts, including, among others: a scarcity and splintering of resources required to conduct research and testing; a lack of knowledge about specific substances and procedures being used and to what degree; and an inconsistent approach to sanctions for those athletes found guilty of doping.

Ever since it entered into force on 1 January 2004, the Code has proven to be a powerful and effective tool in the harmonization of anti-doping efforts worldwide. This has been demonstrated by the overwhelming support of governments and sports in accepting the Code, in addition to the growing body of jurisprudence from the Court of Arbitration for Sport (CAS) in supporting the principles of the Code.

The adoption of the Code led to several significant advances in the global fight against doping in sport, including the formalization of certain rules and the clarification of stakeholder responsibilities. This new approach to anti-doping brought consistency to a previously disjointed system.

The Code has also been instrumental in introducing the concept of “non-analytical” rule violations. Non-analytical rule violations have allowed anti-doping organizations to apply sanctions in cases where there is no positive doping sample, but where there may still be evidence that a doping violation has occurred (e.g. through a combination of three missed tests / whereabouts failures; longitudinal testing; evidence brought forward through an investigation).

WADA International Standard for the Protection of Privacy and Personal Information (ISPPPI) 2009 (1.0)

1 Oct 2008

International Standard for the Protection of Privacy and Personal Information : the World Anti-Doping Code / World Anti-Doping Agency (WADA). - Montreal : WADA, 2008. - (International Standard for the Protection of Privacy and Personal Information (ISPPPI) version 1.0, in effect on 1 January 2009)


The World Anti-Doping International Standard for the Protection of Privacy and Personal Information is a level 2 mandatory International Standard developed as part of the World Anti-Doping Program.

WADA and Anti-Doping Organizations share responsibility for ensuring that Personal Information Processed in connection with anti-doping activities is protected as required by data protection and privacy laws, principles and standards. The main purpose of this International Standard is to ensure that organizations and persons involved in anti-doping in sport apply appropriate, sufficient and effective privacy protections to Personal Information that they Process, regardless of whether this is also required by applicable laws.

A WADA expert reference group reviewed, discussed and prepared this document, and specifically took into account the Organization for Economic Cooperation and Development’s (OECD) 1980 Guidelines on the Protection of Privacy and Transborder Flows of Personal Data; the Council of Europe Convention for the Protection of Individuals with regard to Automatic Processing of Personal Data (ETS. No. 108); Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the processing of personal data and on the free movement of such data, and other international and regional data privacy rules and standards.

The official text of the International Standard for Privacy and Personal Information shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version
shall be controlling.

The International Standard for Privacy and Personal Information shall come into effect on 1 January 2009. It shall be updated from time to time, as needed, to reflect developments in applicable laws and anti-doping practices.

WADA International Standard for the Protection of Privacy and Personal Information (ISPPPI) 2015

20 Feb 2014

Protection of Privacy and Personal Information : World Anti-Doping Code International Standard / World Anti-Doping Agency (WADA). - Montreal : WADA, 2014. - (International Standard for the Protection of Privacy and Personal Information (ISPPPI) effective on 1 January 2015)


The World Anti-Doping Code International Standard for the Protection of Privacy and Personal Information (ISPPPI) is a mandatory International Standard developed as part of the World Anti-Doping Program.

The International Standard for Protection of Privacy and Personal Information was first adopted 9 May 2009 and came into effect 1 June 2009. The enclosed ISPPPI incorporates revisions to the ISPPPI and was approved at the World Conference on Doping in Sport in Johannesburg by the WADA Executive Committee on 15 November 2013. It will come into effect on 1 January 2015.

WADA International Standard for Laboratories (ISL) 2012

19 Nov 2011

World Anti-Doping Code International Standard for Laboratories / World Anti-Doping Agency (WADA). - Montreal : WADA, 2011. - (International Standard for Laboratories (ISL), version 7.0, in force 1 January 2012)



The International Standard for Laboratories was first adopted in June 2003 and became effective on 1 January 2004. The enclosed represents version 7.0 that incorporates revisions to the International Standard for Laboratories that were approved by the World Anti-Doping Agency Executive Committee on 19 November 2011. The revised International Standard for Laboratories is effective as of 1 January 2012.

WADA International Standard for Testing (IST) 2012

4 Oct 2011

The World Anti-Doping Code International Standard for testing / World Anti-Doping Agency (WADA). - Montreal : WADA, 2011. - (The World Anti-Doping Code International Standard for testing (IST) Version 3.0 effective on 1 January 2012)


The International Standard for Testing was first adopted in 2003
and became effective in 2004. Further revisions to the International Standard for Testing were approved by the World Anti-Doping Agency Executive Committee on 10 May 2008.
The enclosed incorporates additional revisions to the International
Standard for Testing that were approved by the World Anti-Doping Agency Executive Committee on 17 September 2011. The revised International Standard for Testing is effective as of 1 January 2012.

The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.

2 Dec 2011

Reichel C. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. Drug Test Anal. 2011 Nov-Dec;3(11-12):883-91. doi: 10.1002/dta.388. Epub 2011 Dec 2.

Erythropoietin and analogs.

1 Jan 2010

Reichel C, Gmeiner G. Erythropoietin and analogs. Handb Exp Pharmacol. 2010;(195):251-94.

SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood.

1 Nov 2009

Reichel C, Abzieher F, Geisendorfer T. SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. Drug Test Anal. 2009 Nov;1(11-12):494-504.

Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin.

23 Apr 2010

Voss S, Lüdke A, Romberg S, Schänzer E, Flenker U, deMarees M, Achtzehn S, Mester J, Schänzer W. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin. Int J Sports Med. 2010 Jun;31(6):367-71. Epub 2010 Apr 23.

False-positive detection of rhEpo remains a real concern

1 Sep 2006

Beullens M, Delanghe JR, Bollen M. False-positive detection of rhEpo remains a real concern. Blood. 2006 Sep 1;108(5): 1779-80.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin